CRISPR Market Report: Trends, Forecast and Competitive Analysis
Get it in 2 to 4 weeks by ordering today
The future of the global CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) market looks promising with opportunities in the biomedical, agricultural, industrial, and biological research applications. The global CRISPR market is expected to grow with a CAGR of 24%-26% from 2020 to 2025. The major drivers for this market are increasing prevalence of genetic diseases, rising geriatric population, and increasing lifestyle oriented diseases.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global CRISPR market report, please download the report brochure.
The study includes trends and forecast for the global CRISPR market by product, service, application, end user, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
Within this market, biomedical will remain the largest segment by application over the forecast period due to CRISPR’s ability to modify endogenous genes that helps in studying the effect of drugs on targets along with endogenous proteins, rather than having to rely on overexpression.
North America will remain the largest region over the forecast period due to increasing government and private fundings and the presence of major gene therapy and pharma companies in the region.
Features of the Global CRISPR Market
Q.1 What are some of the most promising potential, high-growth opportunities for the global CRISPR market by product (enzymes, kits, gRNA, libraries, and design tools), service (gRNA design and cell line engineering), application (biomedical, agricultural, industrial, and biological research), end user (pharma & biopharma companies, biotechnology companies, academics, and contract research organization), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global CRISPR market?
Q.5 What are the business risks and threats to the global CRISPR market?
Q.6 What are the emerging trends in this CRISPR market and the reasons behind them?
Q.7 What are some changing demands of customers in this CRISPR market?
Q.8 What are the new developments in this CRISPR market? Which companies are leading these developments?
Q.9 Who are the major players in this CRISPR market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this CRISPR market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global CRISPR market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product (Enzymes, Kits, gRNA, Libraries, and Design Tools), Service (gRNA Design and Cell Line Engineering), Application (Biomedical, Agricultural, Industrial, and Biological Research), and End User (Pharma & Biopharma Companies, Biotechnology Companies, Academics, and Contract Research Organization)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
The future of the global CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) market looks promising with opportunities in the biomedical, agricultural, industrial, and biological research applications. The global CRISPR market is expected to grow with a CAGR of 24%-26% from 2020 to 2025. The major drivers for this market are increasing prevalence of genetic diseases, rising geriatric population, and increasing lifestyle oriented diseases.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global CRISPR market report, please download the report brochure.
The study includes trends and forecast for the global CRISPR market by product, service, application, end user, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
- Enzymes
- Kits
- gRNA (Guide RNA)
- Libraries
- Design Tools
- gRNA Design
- Cell Line Engineering
- Biomedical
- Agricultural
- Industrial
- Biological Research
- Pharma & Biopharma Companies
- Biotechnology Companies
- Academics
- Contract Research Organization (CROs)
- North America
- United States
- Canada
- Mexico
- Europe
- United Kingdom
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- The Rest of the World
- Brazil
Within this market, biomedical will remain the largest segment by application over the forecast period due to CRISPR’s ability to modify endogenous genes that helps in studying the effect of drugs on targets along with endogenous proteins, rather than having to rely on overexpression.
North America will remain the largest region over the forecast period due to increasing government and private fundings and the presence of major gene therapy and pharma companies in the region.
Features of the Global CRISPR Market
- Market Size Estimates: Global CRISPR market size estimation in terms of value ($M) shipment.
- Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.
- Segmentation Analysis: Global CRISPR market size by various segments, such as product, service, application, and end user in terms of value.
- Regional Analysis: Global CRISPR market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
- Growth Opportunities: Analysis of growth opportunities in different product, service, application, end user, and region for the global CRISPR market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global CRISPR market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
Q.1 What are some of the most promising potential, high-growth opportunities for the global CRISPR market by product (enzymes, kits, gRNA, libraries, and design tools), service (gRNA design and cell line engineering), application (biomedical, agricultural, industrial, and biological research), end user (pharma & biopharma companies, biotechnology companies, academics, and contract research organization), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global CRISPR market?
Q.5 What are the business risks and threats to the global CRISPR market?
Q.6 What are the emerging trends in this CRISPR market and the reasons behind them?
Q.7 What are some changing demands of customers in this CRISPR market?
Q.8 What are the new developments in this CRISPR market? Which companies are leading these developments?
Q.9 Who are the major players in this CRISPR market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this CRISPR market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global CRISPR market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product (Enzymes, Kits, gRNA, Libraries, and Design Tools), Service (gRNA Design and Cell Line Engineering), Application (Biomedical, Agricultural, Industrial, and Biological Research), and End User (Pharma & Biopharma Companies, Biotechnology Companies, Academics, and Contract Research Organization)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
1. EXECUTIVE SUMMARY
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global CRISPR Market Trends and Forecast
3.3: Global CRISPR Market by Product
3.3.1: Enzymes
3.3.2: Kits
3.3.3: gRNA (Guide RNA)
3.3.4: Libraries
3.3.5: Design Tools
3.4: Global CRISPR Market by Service
3.4.1: gRNA Design
3.4.2: Cell Line Engineering
3.5: Global CRISPR Market by Application
3.5.1: Biomedical
3.5.2: Agricultural
3.5.3: Industrial
3.5.4: Biological Research
3.6: Global CRISPR Market by Species
3.6.1: Pharma & Biopharma Companies
3.6.2: Biotechnology Companies
3.6.3: Academics
3.6.4: Contract Research Organization (CROs)
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global CRISPR Market by Region
4.2: North American CRISPR Market
4.2.1: Market by Product: Enzymes, Kits, gRNA, Libraries, and Design Tools
4.2.2: Market by Service: gRNA Design and Cell Line Engineering
4.2.3: Market by Application: Biomedical, Agricultural, Industrial, and Biological Research
4.2.4: Market by End User: Pharma & Biopharma Companies, Biotechnology Companies, Academics, and Contract Research Organization
4.2.5: The United States CRISPR Market
4.2.6: The Canadian CRISPR Market
4.2.7: The Mexican CRISPR Market
4.3: European CRISPR Market
4.3.1: Market by Product: Enzymes, Kits, gRNA, Libraries, and Design Tools
4.3.2: Market by Service: gRNA Design and Cell Line Engineering
4.3.3: Market by Application: Biomedical, Agricultural, Industrial, and Biological Research
4.3.4: Market by End User: Pharma & Biopharma Companies, Biotechnology Companies, Academics, and Contract Research Organization
4.3.5: The CRISPR Market of United Kingdom
4.3.6: The German CRISPR Market
4.3.7: The French CRISPR Market
4.4: APAC CRISPR Market
4.4.1: Market by Product: Enzymes, Kits, gRNA, Libraries, and Design Tools
4.4.2: Market by Service: gRNA Design and Cell Line Engineering
4.4.3: Market by Application: Biomedical, Agricultural, Industrial, and Biological Research
4.4.4: Market by End User: Pharma & Biopharma Companies, Biotechnology Companies, Academics, and Contract Research Organization
4.4.5: The Chinese CRISPR Market
4.4.6: The Indian CRISPR Market
4.4.7: The Japanese CRISPR Market
4.5: ROW CRISPR Market
4.5.1: Market by Product: Enzymes, Kits, gRNA, Libraries, and Design Tools
4.5.2: Market by Service: gRNA Design and Cell Line Engineering
4.5.3: Market by Application: Biomedical, Agricultural, Industrial, and Biological Research
4.5.4: Market by End User: Pharma & Biopharma Companies, Biotechnology Companies, Academics, and Contract Research Organization
4.5.5: Brazilian CRISPR Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global CRISPR Market by Product
7.1.2: Growth Opportunities for the Global CRISPR Market by Service
7.1.3: Growth Opportunities for the Global CRISPR Market by Application
7.1.4: Growth Opportunities for the Global CRISPR Market by End User
7.1.5: Growth Opportunities for the Global CRISPR Market by Region
7.2: Emerging Trends in the Global CRISPR Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global CRISPR Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global CRISPR Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Cellecta, Inc.
8.2: Therm Fisher
8.3: GeneCopoeia, Inc.
8.4: Applied StemCell
8.5: Syntheg Corporation
8.6: OriGene Technologies
8.7: Horizon Discovery
8.8: Merck
8.9: GenScript
8.10: Company
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global CRISPR Market Trends and Forecast
3.3: Global CRISPR Market by Product
3.3.1: Enzymes
3.3.2: Kits
3.3.3: gRNA (Guide RNA)
3.3.4: Libraries
3.3.5: Design Tools
3.4: Global CRISPR Market by Service
3.4.1: gRNA Design
3.4.2: Cell Line Engineering
3.5: Global CRISPR Market by Application
3.5.1: Biomedical
3.5.2: Agricultural
3.5.3: Industrial
3.5.4: Biological Research
3.6: Global CRISPR Market by Species
3.6.1: Pharma & Biopharma Companies
3.6.2: Biotechnology Companies
3.6.3: Academics
3.6.4: Contract Research Organization (CROs)
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global CRISPR Market by Region
4.2: North American CRISPR Market
4.2.1: Market by Product: Enzymes, Kits, gRNA, Libraries, and Design Tools
4.2.2: Market by Service: gRNA Design and Cell Line Engineering
4.2.3: Market by Application: Biomedical, Agricultural, Industrial, and Biological Research
4.2.4: Market by End User: Pharma & Biopharma Companies, Biotechnology Companies, Academics, and Contract Research Organization
4.2.5: The United States CRISPR Market
4.2.6: The Canadian CRISPR Market
4.2.7: The Mexican CRISPR Market
4.3: European CRISPR Market
4.3.1: Market by Product: Enzymes, Kits, gRNA, Libraries, and Design Tools
4.3.2: Market by Service: gRNA Design and Cell Line Engineering
4.3.3: Market by Application: Biomedical, Agricultural, Industrial, and Biological Research
4.3.4: Market by End User: Pharma & Biopharma Companies, Biotechnology Companies, Academics, and Contract Research Organization
4.3.5: The CRISPR Market of United Kingdom
4.3.6: The German CRISPR Market
4.3.7: The French CRISPR Market
4.4: APAC CRISPR Market
4.4.1: Market by Product: Enzymes, Kits, gRNA, Libraries, and Design Tools
4.4.2: Market by Service: gRNA Design and Cell Line Engineering
4.4.3: Market by Application: Biomedical, Agricultural, Industrial, and Biological Research
4.4.4: Market by End User: Pharma & Biopharma Companies, Biotechnology Companies, Academics, and Contract Research Organization
4.4.5: The Chinese CRISPR Market
4.4.6: The Indian CRISPR Market
4.4.7: The Japanese CRISPR Market
4.5: ROW CRISPR Market
4.5.1: Market by Product: Enzymes, Kits, gRNA, Libraries, and Design Tools
4.5.2: Market by Service: gRNA Design and Cell Line Engineering
4.5.3: Market by Application: Biomedical, Agricultural, Industrial, and Biological Research
4.5.4: Market by End User: Pharma & Biopharma Companies, Biotechnology Companies, Academics, and Contract Research Organization
4.5.5: Brazilian CRISPR Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global CRISPR Market by Product
7.1.2: Growth Opportunities for the Global CRISPR Market by Service
7.1.3: Growth Opportunities for the Global CRISPR Market by Application
7.1.4: Growth Opportunities for the Global CRISPR Market by End User
7.1.5: Growth Opportunities for the Global CRISPR Market by Region
7.2: Emerging Trends in the Global CRISPR Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global CRISPR Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global CRISPR Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Cellecta, Inc.
8.2: Therm Fisher
8.3: GeneCopoeia, Inc.
8.4: Applied StemCell
8.5: Syntheg Corporation
8.6: OriGene Technologies
8.7: Horizon Discovery
8.8: Merck
8.9: GenScript
8.10: Company
